Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Enadenotucirev |
| Trade Name | |
| Synonyms | EnAd|ColoAd1|ColoAd-1 |
| Drug Descriptions |
Enadenotucirev is a conditionally-replicating group B adenovirus that has antitumor and immunomodulating activity (PMID: 26708004, PMID: 32532291). |
| DrugClasses | |
| CAS Registry Number | 1402042-02-7 |
| NCIT ID | C113786 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Capecitabine + Enadenotucirev | Capecitabine Enadenotucirev | 0 | 1 |
| Enadenotucirev | Enadenotucirev | 0 | 0 |
| Enadenotucirev + Pembrolizumab | Enadenotucirev Pembrolizumab | 0 | 1 |